{"DataElement":{"publicId":"2749929","version":"1","preferredName":"Antiphospholipid Syndrome Involvement Extent Disease Specify","preferredDefinition":"A syndrome associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses, marked by the presence of antibodies directed against phospholipids._To have a connection by participation or association or use; sharing in an activity or process._the free text field to specify the involvement or extent of disease.","longName":"AN_SY_IN_EX_DI_SP","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2749912","version":"1","preferredName":"Antiphospholipid Syndrome Involvement","preferredDefinition":"A syndrome associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses, marked by the presence of antibodies directed against phospholipids._To have a connection by participation or association or use; sharing in an activity or process.","longName":"ANT_SYN_INV","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2675009","version":"1","preferredName":"Antiphospholipid Syndrome","preferredDefinition":"A syndrome associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses, marked by the  presence of antibodies directed against phospholipids.","longName":"C61283","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antiphospholipid Syndrome","conceptCode":"C61283","definition":"A disorder caused by the presence of autoantibodies directed against phospholipids, causing a hypercoaguable state, which may result in blood clots, stroke, heart attack, and in women, significant pregnancy-related complications, including miscarriage and still birth. The syndrome is often associated with other autoimmune disorders, most commonly lupus erythematosus, and infections, including syphilis and Lyme disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"38B33F67-55F0-3ECE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-27","modifiedBy":"SBREXT","dateModified":"2008-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2192548","version":"1","preferredName":"Involvement","preferredDefinition":"To have a connection by participation or association or use; sharing in an activity or process.","longName":"C25548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9F4C3B9-9218-0989-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-11-29","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D4AF823-AF7F-5557-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2182211","version":"1","preferredName":"Involvement Extent Disease Specify","preferredDefinition":"the free text field to specify the involvement or extent of disease.","longName":"INV_EXT_DZ_SPEC","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184338","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"Specify","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2084-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D6DE6707-9281-1D6F-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"CAMPBELB","dateModified":"2008-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"pre_ted_as_cns_type","type":"NMDP_FN","context":"NHLBI"},{"name":"pre_ted_as_hemat_type","type":"NMDP_FN","context":"NHLBI"},{"name":"pre_ted_as_other_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"pre_ted_as_thromb_type","type":"NMDP_FN","context":"NHLBI"},{"name":" PerformedDiagnosis:resultClassificationCode ","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the other type of ant","type":"Preferred Question Text","description":"Specify the other type of antiphospholipid syndrome involvement:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2749929","type":"BRIDG Mapping Path","description":"PerformedDiagnosis [primary] > AssessedResultRelationship > PerformedObservation [assessment] > AssessedResultRelationship > PerformedDiagnosis.resultClassificationCode(ANY=>CD).originalText [secondary] WHERE PerformedObservation > PerformedObservationResult.value [assessment] = \"involved\" AND PerformedDiagnosis.value [primary] = \"antiphospholipid syndrome\"  AND PerformedDiagnosis [primary] > PerformedProcedure [overall HCT process] AND PerformedObservation [assessment] > DefinedObservation.nameCode = \"Assess Involvement\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D4C481B-23C3-650B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}